Expert Review of Clinical Pharmacology

The use of multi-target drugs in the treatment of neurodegenerative diseases
pp. 293-298(6)
Author: Van der Schyf, Cornelis J

Cardiovascular toxicity of nonsteroidal anti-inflammatory drugs: moving beyond cyclooxygenase selectivity
pp. 299-302(4)
Authors: Mangoni, Arduino A; Crilly, Michael A; Knights, Kathleen M

Clinical pharmacology at the core of translational science
pp. 303-305(3)
Authors: Waldman, Scott A; Terzic, Andre

Sitagliptin could potentially prevent diabetes
pp. 307-309(3)

Methylphenidate transdermal system: clinical applications for attention-deficit/hyperactivity disorder
pp. 311-328(18)
Authors: Elia, Josephine; Wilson, Zoe; La Porta, Lilly Sehgal; Algon, Sibel A; Prowler, Matthew L; Cartwright, Shanique T; McKenna, Patricia A; Laracy, Seth; Takeda, Toshinobu; Borgmann-Winter, Karin

Nab-paclitaxel in the treatment of metastatic breast cancer: a comprehensive review
pp. 329-334(6)
Authors: Montero, Alberto J; Adams, Betsy; Diaz-Montero, C Marcela; Glüück, Stefan

Combating inappropriate use of medicines
pp. 335-348(14)
Author: Holloway, Kathleen Anne

Current challenges in personalizing warfarin therapy
pp. 349-362(14)
Authors: McMillin, Gwendolyn A; Vazquez, Sara R; Pendleton, Robert C

Clinical epidemiology and pharmacology of CYP2D6 inhibition related to breast cancer outcomes
pp. 363-377(15)
Authors: Cronin-Fenton, Deirdre P; Lash, Timothy L

Targeting N-methyl-D-aspartate receptors for treatment of neuropathic pain
pp. 379-388(10)
Authors: Zhou, Hong-Yi; Chen, Shao-Rui; Pan, Hui-Lin

Toward understanding genetic risk for differential antipsychotic response in individuals with schizophrenia
pp. 389-405(17)
Authors: Arranz, Maria J; Munro, Janet C

Acknowledgements
pp. 407-407(1)